This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
DENTSPLY SIRONA (XRAY) Q3 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) third-quarter results benefit from the Technologies & Equipment business.
Myriad Genetics' (MYGN) UroSuite to Improve Tailored Treatment
by Zacks Equity Research
Myriad Genetics' (MYGN) latest launch is expected to aid clinicians with access to tools that can assist them with turnaround times and report interpretation.
Here's Why You Should Retain Patterson Companies (PDCO) Stock
by Zacks Equity Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Beat the Market Like Zacks: JPMorgan, Berkshire Hathaway, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vinci Surgical System. Improving margins buoy optimism.
Patterson Companies (PDCO) Inks Deal to Expand Product Suite
by Zacks Equity Research
Patterson Companies' (PDCO) latest buyout is expected to significantly expand its value-add platform.
October CPI Data Raises Hope for a Soft Landing: 5 Top Picks
by Nalak Das
We have narrowed our search to five U.S. corporate behemoths with solid growth potential. These are: HUM, MPC, CAT, MCK and ORLY.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
Zacks Industry Outlook Highlights Becton Dickinson, McKesson and AmerisourceBergen
by Zacks Equity Research
Becton Dickinson, McKesson and AmerisourceBergen have been highlighted in this Industry Outlook article.
3 Dental Supplies Stocks to Watch Amid Industry Headwinds
by Indrajit Bandyopadhyay
Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.
Zacks.com featured highlights H&R Block, ParkerHannifin, Archer-Daniels-Midland, Insperity and McKesson
by Zacks Equity Research
H&R Block, ParkerHannifin, Archer-Daniels-Midland, Insperity and McKesson have been highlighted in this Screen of The Week article.
3 Reasons Growth Investors Will Love McKesson (MCK)
by Zacks Equity Research
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market.
Top 5 Dividend Stocks to Cheer You Up This Holiday Season
by Sweta Killa
We have selected five dividend growth stocks ¿¿¿ H&R Block (HRB), ParkerHannifin (PH), Archer-Daniels-Midland (ADM), Insperity (NSP) and McKesson (MCK) ¿¿¿ that could be compelling picks for your portfolio ahead of the holiday season.
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
Invest Like Warren Buffett With These 3 Stocks
by Derek Lewis
Many investors mimic Warren Buffett, closely following all of his moves. And with his track record of success, it's easy to see why.
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
McKesson (MCK) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
McKesson's (MCK) fiscal second-quarter 2023 results benefit from segmental growth.
McKesson (MCK) Lags Q2 Earnings Estimates
by Zacks Equity Research
McKesson (MCK) delivered earnings and revenue surprises of -1.14% and 0.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Top 5 Stocks Set to Beat on Earnings After Markets Close
by Nalak Das
Five companies will report earnings results today after the closing bell. These are: CHK, MCK, ENLC, LTHM and ZI.
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
MedTech Stocks Due to Report Earnings on Nov 1: MCK, CTLT & More
by Debanjana Dey
MedTech companies' Q3 results are likely to reflect strength in customer demand. Let's see how MCK, CTLT, ECL, ABMD, HSIC and IDXX are placed ahead of their earnings releases.
Why Earnings Season Could Be Great for McKesson (MCK)
by Zacks Equity Research
McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks.com featured highlights include Heritage-Crystal Clean, Cadence Design Systems, McKesson and Schlumberger
by Zacks Equity Research
Heritage-Crystal Clean, Cadence Design Systems, McKesson and Schlumberger are part of the Zacks Screen of the Week article.
AmerisourceBergen (ABC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pick These 4 Stocks With Excellent Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Heritage-Crystal (HCCI), Cadence (CDNS), McKesson (MCK) and Schlumberger (SLB) are capable of meeting financial obligations.